67445-1-Ig

antibody from Proteintech Group

Targeting: HNRNPA2B1 HNRPA2B1

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

67445-1-Ig

Provider

Proteintech Group

Product name

HNRNPA2B1 antibody

Antibody type

Monoclonal

Description

KD/KO validated HNRNPA2B1 antibody (Cat. #67445-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

3H6F7

Vial size

20ul, 150ul

References

Submitted references

A guide to selecting high-performing antibodies for Heterogeneous nuclear ribonucleoproteins A2/B1(hnRNP A2/B1) (UniProt ID: P22626) for use in western blot, immunoprecipitation, and immunofluorescence.

Moleón VR, Ayoubi R, Alende C, Fothouhi M, Ryan J, Bolívar SG, Worrall D, Durcan TM, Brown CM, Francis V, McPherson PS, Laflamme C
F1000Research 2025;14:1158

---

Integrated Transcriptomic Analysis Leveraging Single-Cell and Bulk RNA Sequencing Data to Uncover Pyroptosis-Related Prognostic Signatures in HCC.

Li J, Di Y, Kang X, Song Z, Sun Z
Journal of hepatocellular carcinoma 2025;12:2971-2988

---

"TFEB-HNRNPA2B1": A positive feedback loop facilitating metastasis in hepatocellular carcinoma cells.

Yan X, Wu Y, Dai X, Wen H, Xiang W, Yang M, Zhang Y, Xiang L, Lu L, Chen A, He F, Lian J
Experimental cell research 2025 Jul 15;450(2):114669

---

Exosome-derived long non-coding RNA AC010789.1 modified by FTO and hnRNPA2B1 accelerates growth of hair follicle stem cells against androgen alopecia by activating S100A8/Wnt/β-catenin signalling.

Chu S, Jia L, Li Y, Xiong J, Sun Y, Zhou Q, Du D, Li Z, Huang X, Jiang H, Wu B, Li Y
Clinical and translational medicine 2025 Jan;15(1):e70152

---

CDC5L binds to ELAVL1 to inhibit pyroptosis in hepatocellular carcinoma through the Caspase 3/GSDME signaling pathway.

Liang S, Zhu Z, Tang Y, Zhou S, Xiao M, Gong X, Ye K
International journal of molecular medicine 2025 Dec;56(6)

---

HnRNPA2B1 tunes antimycobacterial immune responses in macrophages through alternative splicing of Irgm1.

Chapman MJ, Huskey JB, Armijo KS, Hahn S, Spellman-Reliford J, Coleman AK, Mabry CJ, Carpenter S, Watson RO, Patrick KL
bioRxiv : the preprint server for biology 2025 Dec 16;

---

VP3 protein of Senecavirus A promotes viral IRES-driven translation and attenuates innate immunity by specifically relocalizing hnRNPA2B1.

Li L, Li X, Zhong H, Li M, Wan B, He W, Zhang Y, Du Y, Chen D, Zhang W, Ji P, Jiang D, Han S
Journal of virology 2024 Sep 17;98(9):e0122724

---

Localized molecular chaperone synthesis maintains neuronal dendrite proteostasis.

Alecki C, Rizwan J, Le P, Jacob-Tomas S, Comaduran MF, Verbrugghe M, Xu JMS, Minotti S, Lynch J, Biswas J, Wu T, Durham HD, Yeo GW, Vera M
Nature communications 2024 Dec 30;15(1):10796

---

Exosome-delivered NR2F1-AS1 and NR2F1 drive phenotypic transition from dormancy to proliferation in treatment-resistant prostate cancer via stabilizing hormonal receptors.

Chen W, Mao Y, Zhan Y, Li W, Wu J, Mao X, Xu B, Shu F
Journal of nanobiotechnology 2024 Dec 18;22(1):761

---

HNRNPA2B1-mediated m(6)A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.

Li K, Gong Q, Xiang XD, Guo G, Liu J, Zhao L, Li J, Chen N, Li H, Zhang LJ, Zhou CY, Wang ZY, Zhuang L
Journal of translational medicine 2023 Jun 12;21(1):382

---

HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.

Petri BJ, Piell KM, South Whitt GC, Wilt AE, Poulton CC, Lehman NL, Clem BF, Nystoriak MA, Wysoczynski M, Klinge CM
Cancer letters 2021 Oct 10;518:152-168

---

Requirement of splicing factor hnRNP A2B1 for tumorigenesis of melanoma stem cells.

Chu M, Wan H, Zhang X
Stem cell research & therapy 2021 Jan 28;12(1):90